{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:19:59Z","timestamp":1792405199120,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00228-026-04083-x","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:05:12Z","timestamp":1779408312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The influence of hydroxychloroquine on the risk of pre-eclampsia, hypertension, and premature delivery in patients with systemic lupus erythematosus during pregnancy: a meta-analysis"],"prefix":"10.1007","volume":"82","author":[{"given":"Dong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"5","key":"4083_CR1","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.reuma.2016.01.005","volume":"12","author":"F Rivas-Larrauri","year":"2016","unstructured":"Rivas-Larrauri F, Yamazaki-Nakashimada MA (2016) Systemic lupus erythematosus: Is it one disease? Reumatol Clin 12(5):274\u2013281. https:\/\/doi.org\/10.1016\/j.reuma.2016.01.005","journal-title":"Reumatol Clin"},{"issue":"1","key":"4083_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","volume":"80","author":"A Fanouriakis","year":"2021","unstructured":"Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT (2021) Update \u03bfn the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis 80(1):14\u201325. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218272","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"4083_CR3","doi-asserted-by":"publisher","first-page":"e667","DOI":"10.1016\/s2665-9913(24)00160-7","volume":"6","author":"M Wind","year":"2024","unstructured":"Wind M, Fierro JJ, Bloemenkamp KWM, de Leeuw K, Lely AT, Limper M et al (2024) Pregnancy outcome predictors in systemic lupus erythematosus: a systematic review and meta-analysis. Lancet Rheumatol 6(10):e667\u2013e83. https:\/\/doi.org\/10.1016\/s2665-9913(24)00160-7","journal-title":"Lancet Rheumatol"},{"key":"4083_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaut.2017.02.009","volume":"79","author":"PK Bundhun","year":"2017","unstructured":"Bundhun PK, Soogund MZ, Huang F (2017) Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: A meta-analysis of studies published between years 2001\u20132016. J Autoimmun 79:17\u201327. https:\/\/doi.org\/10.1016\/j.jaut.2017.02.009","journal-title":"J Autoimmun"},{"issue":"3","key":"4083_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.7326\/m14-2235","volume":"163","author":"JP Buyon","year":"2015","unstructured":"Buyon JP, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD et al (2015) Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study. Ann Intern Med 163(3):153\u2013163. https:\/\/doi.org\/10.7326\/m14-2235","journal-title":"Ann Intern Med"},{"issue":"5","key":"4083_CR6","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10067-022-06496-2","volume":"42","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wei Y, Zhang Y, Yang H (2023) Hydroxychloroquine significantly decreases the risk of preeclampsia in pregnant women with autoimmune disorders: a systematic review and meta-analysis. Clin Rheumatol 42(5):1223\u20131235. https:\/\/doi.org\/10.1007\/s10067-022-06496-2","journal-title":"Clin Rheumatol"},{"issue":"6","key":"4083_CR7","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/art.42793","volume":"76","author":"A Rector","year":"2024","unstructured":"Rector A, Mari\u0107 I, Chaichian Y, Chakravarty E, Cantu M, Weisman MH et al (2024) Hydroxychloroquine in Lupus Pregnancy and Risk of Preeclampsia. Arthritis Rheumatol 76(6):919\u2013927. https:\/\/doi.org\/10.1002\/art.42793","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"4083_CR8","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/acr.25386","volume":"76","author":"JF Simard","year":"2024","unstructured":"Simard JF, Liu EF, Rector A, Cantu M, Chakravarty E, Druzin M et al (2024) Hydroxychloroquine and Pre-eclampsia in a Diverse Cohort of Women With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) 76(10):1390\u20131395. https:\/\/doi.org\/10.1002\/acr.25386","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"4083_CR9","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/14740338.2017.1269168","volume":"16","author":"C Ponticelli","year":"2017","unstructured":"Ponticelli C, Moroni G (2017) Hydroxychloroquine in systemic lupus erythematosus (SLE). Expert Opin Drug Saf 16(3):411\u2013419. https:\/\/doi.org\/10.1080\/14740338.2017.1269168","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"4083_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.47102\/annals-acadmedsg.2023262","volume":"54","author":"L Kong","year":"2025","unstructured":"Kong L, Wang Q, He Y, Zhang W (2025) Mechanisms and roles of hydroxychloroquine in pregnancy in rheumatic diseases. Ann Acad Med Singap 54(2):113\u2013124. https:\/\/doi.org\/10.47102\/annals-acadmedsg.2023262","journal-title":"Ann Acad Med Singap"},{"key":"4083_CR11","doi-asserted-by":"publisher","unstructured":"Arachchillage DJ, Laffan M, Pericleous C (2023) Hydroxychloroquine as an Immunomodulatory and Antithrombotic Treatment in Antiphospholipid Syndrome. Int J Mol Sci 24(2). https:\/\/doi.org\/10.3390\/ijms24021331","DOI":"10.3390\/ijms24021331"},{"issue":"7","key":"4083_CR12","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1177\/09612033211007199","volume":"30","author":"J Duan","year":"2021","unstructured":"Duan J, Ma D, Wen X, Guo Q, Gao J, Zhang G et al (2021) Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: A meta-analysis. Lupus 30(7):1163\u20131174. https:\/\/doi.org\/10.1177\/09612033211007199","journal-title":"Lupus"},{"issue":"2","key":"4083_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.5468\/ogs.23252","volume":"67","author":"YM Kim","year":"2024","unstructured":"Kim YM, Sung JH, Cha HH, Oh SY (2024) Hydroxychloroquine in obstetrics: potential implications of the prophylactic use of hydroxychloroquine for placental insufficiency during pregnancy. Obstet Gynecol Sci 67(2):143\u2013152. https:\/\/doi.org\/10.5468\/ogs.23252","journal-title":"Obstet Gynecol Sci"},{"key":"4083_CR14","doi-asserted-by":"publisher","unstructured":"Zhu Q, Wang J, Sun Q, Xie Z, Li R, Yang Z et al (2024) Effect of hydroxychloroquine on pregnancy outcome in patients with SLE: a systematic review and meta-analysis. Lupus Sci Med 11(2). https:\/\/doi.org\/10.1136\/lupus-2024-001239","DOI":"10.1136\/lupus-2024-001239"},{"issue":"4","key":"4083_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/acr.24130","volume":"72","author":"LR Sammaritano","year":"2020","unstructured":"Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD et al (2020) American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Care Res (Hoboken) 72(4):461\u2013488. https:\/\/doi.org\/10.1002\/acr.24130","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"4083_CR16","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/rheumatology\/keac558","volume":"62","author":"MD Russell","year":"2023","unstructured":"Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A et al (2023) Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford) 62(4):1370\u20131387. https:\/\/doi.org\/10.1093\/rheumatology\/keac558","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"4083_CR17","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ard.2025.02.023","volume":"84","author":"L R\u00fcegg","year":"2025","unstructured":"R\u00fcegg L, Pluma A, Hamroun S, Cecchi I, Perez-Garcia LF, Anderson PO et al (2025) EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update. Ann Rheum Dis 84(6):910\u2013926. https:\/\/doi.org\/10.1016\/j.ard.2025.02.023","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"4083_CR18","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","volume":"78","author":"MG Tektonidou","year":"2019","unstructured":"Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N et al (2019) EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 78(10):1296\u20131304. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215213","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"4083_CR19","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1177\/0961203315591027","volume":"24","author":"M Leroux","year":"2015","unstructured":"Leroux M, Desveaux C, Parcevaux M, Julliac B, Gouyon JB, Dallay D et al (2015) Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study. Lupus 24(13):1384\u20131391. https:\/\/doi.org\/10.1177\/0961203315591027","journal-title":"Lupus"},{"key":"4083_CR20","doi-asserted-by":"publisher","first-page":"2810202","DOI":"10.1155\/2017\/2810202","volume":"2017","author":"SJ Kroese","year":"2017","unstructured":"Kroese SJ, de Hair MJH, Limper M, Lely AT, van Laar JM, Derksen R et al (2017) Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births. J Immunol Res 2017:2810202. https:\/\/doi.org\/10.1155\/2017\/2810202","journal-title":"J Immunol Res"},{"issue":"9","key":"4083_CR21","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1055\/s-0039-3402752","volume":"37","author":"SC Do","year":"2020","unstructured":"Do SC, Rizk NM, Druzin ML, Simard JF (2020) Does Hydroxychloroquine Protect against Preeclampsia and Preterm Delivery in Systemic Lupus Erythematosus Pregnancies? Am J Perinatol 37(9):873\u2013880. https:\/\/doi.org\/10.1055\/s-0039-3402752","journal-title":"Am J Perinatol"},{"issue":"2","key":"4083_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.autrev.2004.11.009","volume":"4","author":"N Costedoat-Chalumeau","year":"2005","unstructured":"Costedoat-Chalumeau N, Amoura Z, Huong DL, Lechat P, Piette JC (2005) Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature. Autoimmun Rev 4(2):111\u2013115. https:\/\/doi.org\/10.1016\/j.autrev.2004.11.009","journal-title":"Autoimmun Rev"},{"issue":"11","key":"4083_CR23","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1055\/s-0040-1715140","volume":"42","author":"R Abd Rahman","year":"2020","unstructured":"Abd Rahman R, Min Tun K, Kamisan Atan I, Mohamed Said MS, Mustafar R, Zainuddin AA (2020) New Benefits of Hydroxychloroquine in Pregnant Women with Systemic Lupus Erythematosus: A Retrospective Study in a Tertiary Centre. Rev Bras Ginecol Obstet 42(11):705\u2013711. https:\/\/doi.org\/10.1055\/s-0040-1715140","journal-title":"Rev Bras Ginecol Obstet"},{"key":"4083_CR24","doi-asserted-by":"publisher","unstructured":"Liu EL, Liu Z, Zhou YX (2018) Feasibility of hydroxychloroquine adjuvant therapy in pregnant women with systemic lupus erythematosus. Allied Acad (5). https:\/\/doi.org\/10.4066\/biomedicalresearch.29-17-3539","DOI":"10.4066\/biomedicalresearch.29-17-3539"},{"issue":"5","key":"4083_CR25","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1093\/rheumatology\/keaa592","volume":"60","author":"NW Andersson","year":"2021","unstructured":"Andersson NW, Skov L, Andersen JT (2021) Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort study. Rheumatology (Oxford) 60(5):2317\u20132326. https:\/\/doi.org\/10.1093\/rheumatology\/keaa592","journal-title":"Rheumatology (Oxford)"},{"key":"4083_CR26","doi-asserted-by":"publisher","first-page":"115314","DOI":"10.1016\/j.intimp.2025.115314","volume":"163","author":"Z Qin","year":"2025","unstructured":"Qin Z, Long Y (2025) Immunological dysregulation in preeclampsia: Pathogenesis and clinical implications. Int Immunopharmacol 163:115314. https:\/\/doi.org\/10.1016\/j.intimp.2025.115314","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4083_CR27","doi-asserted-by":"publisher","first-page":"e202451298","DOI":"10.1002\/eji.202451298","volume":"55","author":"H Guo","year":"2025","unstructured":"Guo H, Liang Q, Xue Z, Yang J, Chen P, Ji J et al (2025) Neutrophil Extracellular Traps Participate in the Pathogenesis of Lupus Through S100A10-Mediated Regulatory T-Cell Differentiation and Functional Abnormalities. Eur J Immunol 55(1):e202451298. https:\/\/doi.org\/10.1002\/eji.202451298","journal-title":"Eur J Immunol"},{"key":"4083_CR28","doi-asserted-by":"publisher","first-page":"859260","DOI":"10.3389\/fimmu.2022.859260","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Li Z, Chen G, Li Z, Huang J, Huang H et al (2022) Hydroxychloroquine Alleviates EAU by Inhibiting Uveitogenic T Cells and Ameliorating Retinal Vascular Endothelial Cells Dysfunction. Front Immunol 13:859260. https:\/\/doi.org\/10.3389\/fimmu.2022.859260","journal-title":"Front Immunol"},{"key":"4083_CR29","doi-asserted-by":"publisher","first-page":"117968","DOI":"10.1016\/j.biopha.2025.117968","volume":"186","author":"MS Hsieh","year":"2025","unstructured":"Hsieh MS, Liu HW, Guo FY, Song DP, Li MY, Chao TY et al (2025) S-hydroxychloroquine prevents the antiphospholipid thrombogenic complexes for antiphospholipid syndrome treatment. Biomed Pharmacother 186:117968. https:\/\/doi.org\/10.1016\/j.biopha.2025.117968","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"4083_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jogn.2025.05.118","volume":"54","author":"SS Hawkins","year":"2025","unstructured":"Hawkins SS (2025) Low-Dose Aspirin Prophylaxis to Prevent Preeclampsia. J Obstet Gynecol Neonatal Nurs 54(4):389\u2013401. https:\/\/doi.org\/10.1016\/j.jogn.2025.05.118","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"issue":"6","key":"4083_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1191\/096120301678646137","volume":"10","author":"RA Levy","year":"2001","unstructured":"Levy RA, Vilela VS, Cataldo MJ, Ramos RC, Duarte JL, Tura BR et al (2001) Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 10(6):401\u2013404. https:\/\/doi.org\/10.1191\/096120301678646137","journal-title":"Lupus"},{"issue":"2","key":"4083_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ajog.2015.09.078","volume":"214","author":"S Sciascia","year":"2016","unstructured":"Sciascia S, Hunt BJ, Talavera-Garcia E, Lliso G, Khamashta MA, Cuadrado MJ (2016) The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies. Am J Obstet Gynecol 214(2):273.e1-.e8. https:\/\/doi.org\/10.1016\/j.ajog.2015.09.078","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"4083_CR33","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1161\/hypertensionaha.114.03587","volume":"64","author":"M G\u00f3mez-Guzm\u00e1n","year":"2014","unstructured":"G\u00f3mez-Guzm\u00e1n M, Jim\u00e9nez R, Romero M, S\u00e1nchez M, Zarzuelo MJ, G\u00f3mez-Morales M et al (2014) Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus. Hypertension 64(2):330\u2013337. https:\/\/doi.org\/10.1161\/hypertensionaha.114.03587","journal-title":"Hypertension"},{"issue":"6","key":"4083_CR34","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1136\/annrheumdis-2017-212535","volume":"77","author":"AM Eudy","year":"2018","unstructured":"Eudy AM, Siega-Riz AM, Engel SM, Franceschini N, Howard AG, Clowse MEB et al (2018) Effect of pregnancy on disease flares in patients with systemic lupus erythematosus. Ann Rheum Dis 77(6):855\u2013860. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212535","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4083_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/bcp.14131","volume":"86","author":"C de Moreuil","year":"2020","unstructured":"de Moreuil C, Alavi Z, Pasquier E (2020) Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage. Br J Clin Pharmacol 86(1):39\u201349. https:\/\/doi.org\/10.1111\/bcp.14131","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"4083_CR36","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1002\/art.11304","volume":"48","author":"N Costedoat-Chalumeau","year":"2003","unstructured":"Costedoat-Chalumeau N, Amoura Z, Duhaut P, Huong DL, Sebbough D, Wechsler B et al (2003) Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum 48(11):3207\u20133211. https:\/\/doi.org\/10.1002\/art.11304","journal-title":"Arthritis Rheum"},{"issue":"5","key":"4083_CR37","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1365-2125.2008.03111.x","volume":"65","author":"I Law","year":"2008","unstructured":"Law I, Ilett KF, Hackett LP, Page-Sharp M, Baiwog F, Gomorrai S et al (2008) Transfer of chloroquine and desethylchloroquine across the placenta and into milk in Melanesian mothers. Br J Clin Pharmacol 65(5):674\u2013679. https:\/\/doi.org\/10.1111\/j.1365-2125.2008.03111.x","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"4083_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/00007691-198802000-00004","volume":"10","author":"A Akintonwa","year":"1988","unstructured":"Akintonwa A, Gbajumo SA, Mabadeje AF (1988) Placental and milk transfer of chloroquine in humans. Ther Drug Monit 10(2):147\u2013149. https:\/\/doi.org\/10.1097\/00007691-198802000-00004","journal-title":"Ther Drug Monit"},{"issue":"4","key":"4083_CR39","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/art.10150","volume":"46","author":"N Costedoat-Chalumeau","year":"2002","unstructured":"Costedoat-Chalumeau N, Amoura Z, Aymard G, Le TH, Wechsler B, Vauthier D et al (2002) Evidence of transplacental passage of hydroxychloroquine in humans. Arthritis Rheum 46(4):1123\u20131124. https:\/\/doi.org\/10.1002\/art.10150","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4083_CR40","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/art.38262","volume":"66","author":"WO Cooper","year":"2014","unstructured":"Cooper WO, Cheetham TC, Li DK, Stein CM, Callahan ST, Morgan TM et al (2014) Brief report: Risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancy. Arthritis Rheumatol 66(2):444\u2013450. https:\/\/doi.org\/10.1002\/art.38262","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"4083_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/157488606775252584","volume":"1","author":"F Nosten","year":"2006","unstructured":"Nosten F, McGready R, d\u2019Alessandro U, Bonell A, Verhoeff F, Menendez C et al (2006) Antimalarial drugs in pregnancy: a review. Curr Drug Saf 1(1):1\u201315. https:\/\/doi.org\/10.2174\/157488606775252584","journal-title":"Curr Drug Saf"},{"issue":"5","key":"4083_CR42","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/bcp.12872","volume":"81","author":"YC Kaplan","year":"2016","unstructured":"Kaplan YC, Ozsarfati J, Nickel C, Koren G (2016) Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis. Br J Clin Pharmacol 81(5):835\u2013848. https:\/\/doi.org\/10.1111\/bcp.12872","journal-title":"Br J Clin Pharmacol"},{"key":"4083_CR43","doi-asserted-by":"publisher","unstructured":"Rajput R, Upadhyay P, Rajput S, Saini S, Kharab S (2023) Effect of hydroxychloroquine on beta cell function, insulin resistance, and inflammatory markers in type 2 diabetes patients uncontrolled on glimepiride and metformin therapy. Int J Diabetes Dev Ctries 1\u20136. https:\/\/doi.org\/10.1007\/s13410-023-01173-9","DOI":"10.1007\/s13410-023-01173-9"},{"issue":"10","key":"4083_CR44","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1007\/s00125-015-3689-2","volume":"58","author":"MC Wasko","year":"2015","unstructured":"Wasko MC, McClure CK, Kelsey SF, Huber K, Orchard T, Toledo FG (2015) Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial. Diabetologia 58(10):2336\u20132343. https:\/\/doi.org\/10.1007\/s00125-015-3689-2","journal-title":"Diabetologia"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04083-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04083-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04083-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:17:44Z","timestamp":1781072264000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04083-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4083"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04083-x","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"15 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"155"}}